Pursuant to section 23(4A) of the Medicines Act 1981, the Minister of Health hereby renews the provisional consent to the sale, supply or use in New Zealand of the medicines set out in the Schedule hereto:
Schedule
Product: Bicillin L-A
Active Ingredient: Benzathine benzylpenicillin tetrahydrate 450mg/mL
Dosage Form: Suspension for injection
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturers: Wyeth Pharmaceuticals Inc, West Chester, United States of America
King Pharmaceuticals Inc, Rochester, United States of America
Note: This renewed consent is valid for two years from 7 August 2010.
Product: Potassium 10mmol
Active Ingredient: Potassium chloride 7.385g/L
Dosage Form: Solution for infusion
New Zealand Sponsor: Baxter Healthcare Limited
Manufacturer: Baxter Healthcare Pty Limited, Old Toongabbie, Australia
Note: This renewed consent is valid for two years from 12 June 2010.
Product: Potassium 40mmol
Active Ingredient: Potassium chloride 2.95g/L
Dosage Form: Solution for infusion
New Zealand Sponsor: Baxter Healthcare Limited
Manufacturer: Baxter Healthcare Pty Limited, Old Toongabbie, Australia
Note: This renewed consent is valid for two years from 12 June 2010.
Dated this 3rd day of June 2010.
STEWART JESSAMINE, Acting Deputy Director-General, Regulation and Governance Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).